Skip to main content

Advanced Search

Projected result for your current search:: 0

Search Operators:

You can use operators in your search query to narrow down your results even more. Click on the search operator to see an explanation of how it works.
Finds documents with exactly this word group, in exactly this word order and spelling (e.g. "employer branding").
Finds documents with both search terms (e.g. sales AND bonus).
Finds documents with one or the other search term (e.g. porsche OR volkswagen).
Finds documents with all search terms. Blank space is understood as AND (e.g. man robot production).
Finds documents with no appearance of the word behind NOT (e.g. ford NOT "harrison ford").
Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g. COUNT(gear)>8).
Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Finds documents with the search term in different spellings. "?" allows only one character (e.g. organi?ation).
Special characters are understood as AND (e.g. Miller Bros. & Sons).
 Log in
Top

Drugs

Issue 17/2020

Content (11 Articles)

New Agents in Development for Sepsis: Any Reason for Hope?

Philippe Vignon, Pierre-François Laterre, Thomas Daix, Bruno François

Pharmacological Management of Glucose Dysregulation in Patients Treated with Second-Generation Antipsychotics

Simona Cernea, Lorena Dima, Christoph U. Correll, Peter Manu

First-Line Immune Checkpoint Inhibition for Advanced Non-Small-Cell Lung Cancer: State of the Art and Future Directions

Christoph Jakob Ackermann, Helen Adderley, Ana Ortega-Franco, Adeel Khan, Martin Reck, Raffaele Califano

Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent

Mario Cazzola, Clive Page, Paola Rogliani, Luigino Calzetta, Maria Gabriella Matera

Targeting HER2 in Breast Cancer: Latest Developments on Treatment Sequencing and the Introduction of Biosimilars

Megan E. Tesch, Karen A. Gelmon

Efficacy of Montelukast in Allergic Rhinitis Treatment: A Systematic Review and Meta-Analysis

Madhusudhan Krishnamoorthy, Norhayati Mohd Noor, Norhafiza Mat Lazim, Baharudin Abdullah

Risdiplam: First Approval

Sohita Dhillon

Imlifidase: First Approval

Zaina T. Al-Salama

Pralsetinib: First Approval

  • NSCLC
  • AdisInsight Report

Anthony Markham

Correction to: Oliceridine: First Approval

  • Correction

Anthony Markham

Correction to: Triheptanoin: First Approval

  • Open Access
  • Correction

Matt Shirley

Nov 20
Issue: 16/2020
Dec 20
Issue: 18/2020

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images